Morio, Yoshiteru, and Ivan F. McMurtry. Ca 2ϩ release from ryanodine-sensitive store contributes to mechanism of hypoxic vasoconstriction in rat lungs. J Appl Physiol 92: 527-534, 2002.-Studies of thapsigargin, cyclopiazonic acid, and ryanodine in isolated pulmonary arteries and smooth muscle cells suggest that release of Ca 2ϩ from inositol 1,4,5-trisphosphate (IP3)-and/or ryanodine-sensitive sarcoplasmic reticulum Ca 2ϩ stores is a component of the mechanism of acute hypoxic pulmonary vasoconstriction (HPV). However, the actions of these agents on HPV in perfused lungs have not been reported. Thus we tested effects of thapsigargin and cyclopiazonic acid, inhibitors of sarcoplasmic reticulum Ca 2ϩ -ATPase, and of ryanodine, an agent that either locks the ryanodine receptor open or blocks it, on HPV in salt solution-perfused rat lungs. After inhibition of cyclooxygenase and nitric oxide synthase, thapsigargin (10 nM) and cyclopiazonic acid (5 M) augmented the vasoconstriction to 0% but not to 3% inspired O2. Relatively high concentrations of ryanodine (100 and 300 M) blunted HPV in nitric oxide synthase-inhibited lungs. The results indicate that release of Ca 2ϩ from the ryanodine-sensitive, but not the IP3-sensitive, store, contributes to the mechanism of HPV in perfused rat lungs and that Ca 2ϩ -ATPase-dependent Ca 2ϩ buffering moderates the response to severe hypoxia. pulmonary circulation; pulmonary vasoregulation; hypoxia; intracellular calcium STUDIES IN PERFUSED LUNGS (2, 11, 23, 40) , catheterized animals (27, 31, 39, 44, 55) , and human subjects (26, 38) show inhibition of acute hypoxic pulmonary vasoconstriction (HPV) by voltage-gated Ca 2ϩ channel blockers, such as verapamil and nifedipine. In addition, HPV is potentiated by the voltage-gated Ca 2ϩ channel facilitator BAY K 8644 (22, 43) and the voltage-gated and Ca 2ϩ -activated K ϩ channel blockers 4-aminopyridine and tetraethylammonium chloride (2, 11, 12) and inhibited by ATP-sensitive K ϩ channel activators (2, 11, 12, 27, 36, 53) . These pharmacological observations indicate that vascular smooth muscle membrane depolarization and Ca 2ϩ influx through L-type Ca 2ϩ channels are important components of the mechanism of HPV. This idea is supported by electrophysiological studies of isolated pulmonary arteries and pulmonary artery smooth muscle cells (PASMC) that show that hypoxia can cause inhibition of voltagegated K ϩ channels, membrane depolarization, and Ca 2ϩ influx (for recent reviews, see Refs. 1, 5, 19, 21, 41, 51). Collectively, these studies lead to the concept that the mechanism of HPV comprises hypoxic inhibition of a vascular smooth muscle voltage-gated K ϩ channel, membrane depolarization, opening of L-type Ca 2ϩ channels, Ca 2ϩ influx, and contraction. In contrast, another body of work in isolated pulmonary arteries and PASMC suggests that hypoxia-induced release of Ca 2ϩ from intracellular sarcoplasmic reticulum (SR) stores, such as the ryanodine receptorsensitive, or Ca 2ϩ -induced Ca 2ϩ -release (CICR) store, and the inositol 1,4,5-trisphosphate (IP 3 ) receptor-sensitive Ca 2ϩ store, is a component of the mechanism of HPV. Thus caffeine, an agent that activates and depletes ryanodine-sensitive Ca 2ϩ stores (16), inhibited hypoxia-induced increases in intracellular Ca 2ϩ in rat PASMC (34) and hypoxic suppression of K ϩ currents in dog PASMC (29). In addition, ryanodine, an agent that depending on concentration either locks the ryanodine receptor open or blocks it (16), inhibited hypoxia-induced increases in cytoplasmic Ca 2ϩ in cat (45), rat (10), and lamb (6) PASMC. Ryanodine also blunted hypoxic contraction of dog pulmonary arteries (13) and blocked the hypoxic response of pig pulmonary arteries (18). Whereas one study of rat pulmonary arteries found blockade of hypoxic contraction by ryanodine (10), two other studies did not (15, 33) . The combination of caffeine and ryanodine inhibited hypoxia-induced increases in intracellular Ca 2ϩ in rabbit PASMC (9) and abolished both the initial transient and secondary sustained phases of the biphasic hypoxic contraction of rat and rabbit pulmonary arteries (8, 9). Similarly, although thapsigargin and cyclopiazonic acid, inhibitors of SR Ca 2ϩ -ATPase and the uptake of Ca 2ϩ into IP 3 -sensitive Ca 2ϩ stores (16), inhibited hypoxic increases in cytoplasmic Ca 2ϩ in rat PASMC (10, 34) and the initial hypoxic contractions of rat pulmonary arteries (8, 10, 33) , these agents potentiated sustained hypoxic contractions of dog pulmonary arteries (13). Although these observations are somewhat discordant, they indicate collectively that release of Ca 2ϩ from
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METHODS

Animals.
Experiments were performed with adult male Sprague-Dawley rats (300-400 g) that were kept at Denver's altitude of 5,280 ft (barometric pressure ϳ630 mmHg, inspired O2 tension ϳ122 Torr). The rats were housed under a 12:12-h light-dark cycle and allowed free access to standard rat food and water. All experimental procedures were approved by the Animal Care and Use Committee of the University of Colorado Health Sciences Center.
Isolated perfused lungs. Lungs were isolated from rats after anesthesia with intraperitoneal pentobarbital sodium (30 mg) and an intracardiac injection of 100 IU of heparin as previously described (11, 12, 25, 36, 37) . Isolated lungs were ventilated with a humid mixture of 21% O2-5% CO2-74% N2 at 60 breaths/min, an inspiratory pressure of 9 cmH2O, and an end-expiratory pressure of 2.5 cmH2O. They were perfused through a main pulmonary artery cannula with peristaltic pump at a constant flow of 0.04 ml ⅐ g body wt Ϫ1 ⅐ min Ϫ1 . Mean perfusion pressure was continuously measured with a transducer and pen recorder. The perfusate was a PSS containing (in mM) 116.3 NaCl, 5.4 KCl, 0.83 MgSO4, 19.0 NaHCO3, 1.04 NaH2PO4, 1.8 CaCl2 ⅐ 2H2O, and 5.5 D-glucose (Earle's balanced salt solution; Sigma Chemical). Ficoll (4 g/100 ml, type 70; Sigma Chemical) was included as a colloid, and 3.1 M sodium meclofenamate (Sigma Chemical) was added to inhibit synthesis of vasodilator prostaglandins (27, 36) . After lungs were flushed of blood with 20 ml of PSS, they were perfused with a recirculated volume of 30 ml. Effluent perfusate drained from a left ventricular cannula into a perfusate reservoir located below the level of the lung. The perfusate reservoir volume was continuously monitored, and any lung preparation that leaked perfusate or became overtly edematous was excluded from the study. Lung and perfusate temperatures were maintained at 37°C, and perfusate pH was kept between 7.3 and 7.4.
The PSS-perfused lungs were equilibrated for 20 min before two hypoxic pressor responses were elicited by ventilation with either 0% O 2-5% CO2-95% N2 or 3% O2-5% CO2-92% N 2 for 10 min at 20- (37) . Because of some oxygenation of the recirculated perfusate by room air in the unsealed reservoir and possibly through the walls of the tubing, the corresponding O 2 tensions of the influent perfusate were ϳ120, 46, and 33 Torr. Because the lungs were ventilated at constant airway pressures and perfused at constant flow under zone 2 conditions, changes in perfusion pressure reflected changes in pulmonary vascular resistance. The vascular effects of the inhibitors of SR Ca 2ϩ release were analyzed by measuring baseline (normoxic) perfusion pressure and the peak of the hypoxic pressor response. In addition, the percent spontaneous reversal (dilation) of the hypoxic vasoconstriction that occurred within 2 min of the peak of the response (11, 12) was measured during the second hypoxic response elicited 40 min after treatment with either vehicle or inhibitor. To control for differences in vascular reactivity over time of perfusion and with repeated hypoxic challenges, SR Ca 2ϩ inhibitor lungs and the respective vehicle control lungs were treated identically with respective to time and hypoxic challenges.
Experimental protocols. Because thapsigargin and cyclopiazonic acid stimulate endothelial NO synthesis (24, 25, 56) , the first set of experiments compared the separate effects of the two inhibitors of SR Ca 2ϩ -ATPase on HPV in PSSperfused rat lungs either pretreated or not with the inhibitor of NO synthase nitro-L-arginine (L-NNA) (Aldrich). After equilibration and two initial challenges with 0% O2, lungs were treated by adding either 60 l saline (vehicle control) or 200 M L-NNA (25, 36) to the perfusate. Fifteen minutes later, a third hypoxic challenge was given, and then either DMSO (vehicle; 30 l), thapsigargin (Calbiochem; 10 nM) (4, 25) , or cyclopiazonic acid (Calbiochem; 5 M) (8, 10, 13, 16) was added to the perfusate. After an additional 15 min, the lungs were again challenged twice with 0% O2 ventilation for 15 min, with 10 min of normoxic ventilation between the two challenges.
Although there is no clear evidence that ryanodine stimulates NO synthesis, the second experiment compared effects of the ryanodine-receptor inhibitor on the response to 0% O2 in lungs either pretreated or not with L-NNA to control for any possible interaction between NO and ryanodine-sensitive Ca 2ϩ stores (28, 35) . The protocol was identical to that described above for the Ca 2ϩ -ATPase inhibitors except either 30 l distilled H2O (vehicle) or 10 M ryanodine (10, 13, 15, 18, 33, 45) was added to the perfusate of untreated and L-NNA-pretreated lungs 15 min before the final two hypoxic challenges. The effects of a fivefold higher concentration of ryanodine (50 M) (30, 35) were also examined in additional L-NNA-pretreated lungs.
To test whether a possible role of release of intracellular Ca 2ϩ in HPV might depend on the severity of hypoxia, a third experiment examined the separate effects of thapsigargin and ryanodine in L-NNA-pretreated lungs challenged with 3% O2 instead of 0% O2. The protocol was as described in the preceding paragraphs except lungs were challenged with 3% O2 instead of 0% O2 before and after addition of 200 M L-NNA and either 30 l DMSO or distilled H2O (vehicles), 10 nM thapsigargin, or 10 M ryanodine to the perfusate. In view of the recent report that the cADP-ribose antagonist 8-bromo-cADP-ribose blocks HPV in rat lungs (8) , and to enhance our confidence that a sufficiently high concentration of ryanodine was used (14) , the effects of 100 and 300 M ryanodine were tested in additional L-NNA-pretreated lungs challenged with 3% O 2. Also, 0.1 M nifedipine (11, 16) was added to the perfusate at the peak of a third posttreatment hypoxic response to test for involvement of voltage-gated Ca 2ϩ influx in the ongoing HPV in lungs treated with either vehicle or 100 M ryanodine.
Statistics. Data are expressed as means Ϯ SE. Statistical analysis was done by either unpaired t-test or repeatedmeasures ANOVA followed by Dunn-type multiple comparisons. Differences were considered significant at P Ͻ 0.05.
RESULTS
In the first experiment, cyclopiazonic acid, but not thapsigargin, caused a slight increase in baseline (normoxic) perfusion pressure in lungs either pretreated or not with L-NNA (Table 1) . Whereas both agents reduced the peak of the pressor response to 0% O 2 in lungs not pretreated with L-NNA, they augmented the response in lungs pretreated with the NO synthase inhibitor (Fig. 1) . Representative perfusion pressure tracings in L-NNA-pretreated lungs are shown in Fig. 2 . Although both thapsigargin and cyclopiazonic acid augmented the peak of the hypoxic response, neither agent prevented the marked spontaneous reversal (dilation) of the vasoconstriction ( Fig. 2 and Table 2 ). In the second experiment, neither 10 nor 50 M ryanodine had any effect on either baseline perfusion pressure (Table 1) or the pressor response to 0% O 2 in lungs either pretreated or not with L-NNA (Fig. 3) . Ryanodine also did not affect the spontaneous reversal of hypoxic vasoconstriction in L-NNA-pretreated lungs ( Fig. 2 and Table 2 ).
In the third experiment with L-NNA-pretreated lungs challenged with 3% O 2 instead of 0% O 2 , 10 nM thapsigargin neither increased baseline perfusion pressure (Table 1) nor affected either the peak (Fig. 4) or the spontaneous reversal ( Fig. 2 and Table 2 ) of the hypoxic pressor response. Whereas neither 10, 100, nor 300 M ryanodine affected baseline perfusion pressure (Table 1) , 100 M ryanodine tended to blunt the peak hypoxic vasoconstriction, and the inhibition by 300 M was statistically significant (Fig. 5) . The percent spontaneous reversal of hypoxic vasoconstriction was increased in lungs treated with 300 M but not with 100 M, ryanodine (Table 2) . Representative perfusion pressure tracings of effects of 300 M ryanodine on HPV are shown in Fig. 2 . In lungs treated with 100 M ryanodine, 0.1 M nifedipine caused immediate and marked inhibition of the residual, ongoing hypoxic vasoconstriction (Fig. 6) .
DISCUSSION
This study showed that the effects of thapsigargin and cyclopiazonic acid on HPV in PSS-perfused rat lungs depended on whether lungs had been pretreated with an inhibitor of NO synthase and on the severity of hypoxic challenge. Whereas both inhibitors of SR Ca 2ϩ -ATPase blunted the pressor response to 0% O 2 in the absence of L-NNA, they augmented the response after inhibition of NO synthesis. However, thapsigargin did not augment the pressor response to 3% O 2 in L-NNApretreated lungs. Because blunting of HPV by thapsigargin and cyclopiazonic acid in the absence of L-NNA was apparently due to increased synthesis of the vasodilator NO (24, 25, 56) , these results provide no evidence that release of Ca 2ϩ from IP 3 -sensitive SR stores is an important component of the mechanism of HPV in perfused rat lungs. In contrast, relatively high concentrations of ryanodine blunted HPV in L-NNA-pretreated lungs, a finding consistent with the possibility that release of Ca 2ϩ from the ryanodine-sensitive, CICR SR store contributes to the overall mechanism of HPV.
A limitation of this study is that we had no independent measure of the effects of thapsigargin and cyclopiazonic acid or of ryanodine on release of SR Ca 2ϩ in the PASMC of the perfused lung. The 5 M concentration of cyclopiazonic acid used in our study was similar to that used to inhibit Ca 2ϩ -ATPase and deplete IP 3 -sensitive Ca 2ϩ stores in isolated arteries and smooth muscle cells (8, 10, 13, 16) . Because concentrations of thapsigargin Ͼ30 nM caused edema in PSS-perfused rat lungs (4), we limited its concentration to 10 nM, which was lower than the 1-5 M generally used in vitro (10, 13, 16) . However, our laboratory has previously observed that 10 nM thapsigargin causes contraction of isolated rat pulmonary arteries (25) , which suggests that this concentration is sufficient to inhibit Ca 2ϩ -ATPase in rat conduit PASMC. Despite the different concentrations, the two inhibitors of Ca 2ϩ -ATPase had very similar effects on pulmonary vasoreactivity. Only cyclopiazonic acid caused a slight increase in baseline perfusion pressure, but both agents blunted the pressor response to 0% O 2 in the absence of L-NNA and augmented the response in the presence of L-NNA. Although the 10 M concentration of ryanodine used in our initial experiments has been commonly used in studies of isolated arteries and PASMC (6, 10, 13, 15, 18, 33, 45) and has been found in some cases to inhibit hypoxic responses (6, 10, 13, 18, 45) , it had no effect on HPV in the perfused lungs. Because some reports indicate that concentrations as high as 300 M are required to inhibit release of Ca 2ϩ from the CICR store (14), we also examined the effects of 100 and 300 M ryanodine and observed significant blunting of HPV by the highest concentration. We attempted in preliminary experiments to use caffeine-induced vasoconstriction to test for the effectiveness of ryanodine blockade of CICR (13, 14, 33) but found that 10 mM caffeine caused vasodilation rather than vasoconstriction in meclofenamate-and L-NNA-pretreated rat lungs (unpublished observations).
Our observation that thapsigargin and cyclopiazonic acid augmented the pressor response to 0% O 2 is similar to that of Jabr et al. (13) , who observed potentiation of hypoxic (0% O 2 ) contraction of dog pulmonary arteries by these inhibitors of SR Ca 2ϩ -ATPase. A difference between the studies is that we found potentiation of the hypoxic response only after inhibition of NO synthesis, whereas a NO synthase inhibitor was not used in the isolated pulmonary arteries. The arteries were isolated with functional endothelium (13) , and it is unclear why endothelial NO production in response to the Ca 2ϩ -ATPase inhibitors (24, 25, 56) was apparently not an issue. Because the larger hypoxic contractions of isolated arteries after thapsigargin or cyclopiazonic acid were less sensitive to inhibition by L-type Ca 2ϩ channel blockers than were the control responses, Jabr et al. (13) speculated that additional Ca 2ϩ influx through a dihydropyridine-insensitive pathway contributed to the potentiation. We did not examine this possibility in the perfused lungs, and the potentiation of HPV might have been due to a similar mechanism and/or to a reduction in the ability of SR Ca lated rat pulmonary arteries by thapsigargin and/or cyclopiazonic acid.
We are also uncertain why thapsigargin potentiated HPV to 0% O 2 but not to 3% O 2 in L-NNA-pretreated lungs. It can be speculated that if potentiation of the peak response to 0% O 2 by thapsigargin were due to inhibition of Ca 2ϩ buffering by SR Ca 2ϩ -ATPase (46), then possibly the buffering was greater during the response to 0% O 2 than during that to 3% O 2 . In view of evidence that severe hypoxia stimulates Ca 2ϩ -ATPase-dependent Ca 2ϩ uptake in rabbit pulmonary arteries (49) , such a difference is feasible. In contrast, potentiation of the peak response to 0% O 2 by the inhibitors of Ca 2ϩ -ATPase was apparently not due to attenuation of the spontaneous reversal (dilation) of the response, because the dilation was not reduced by either thapsigargin or cyclopiazonic acid. This agrees with evidence that the spontaneous reversal of vasoconstriction to severe hypoxia in perfused lungs is due largely to stimulation of ATP-sensitive and Ca 2ϩ -activated K ϩ channels and the resulting membrane hyperpolarization and inhibition of voltage-gated Ca 2ϩ influx (11, 12, 53) .
Previous studies of effects of ryanodine on hypoxic contraction of isolated arteries have produced mixed results. Gelband and Gelband (10) and Liu et al. (18) found complete blockade of hypoxic contraction of rat and pig pulmonary arteries by 5 and 10 M ryanodine, respectively, and Jabr et al. (13) observed blunting of hypoxic contraction of dog pulmonary arteries. In contrast, Jin et al. (15) reported no effect of 10 M ryanodine on hypoxic contraction of rat pulmonary arteries. Saqueton et al. (35) infused ryanodine into the pulmonary artery of fetal lambs and observed that although it inhibited inhaled NO-induced pulmonary vasodilation, it had no effect on hypoxic pulmonary vascular tone. Whereas Dipp and Evans (8) reported complete blockade of hypoxic contraction of rat pulmonary arteries by 10 M ryanodine plus 10 mM caffeine, this combination caused only slight inhibition in the study of Robertson et al. (33) . There is no evident explanation for these disparate findings. In our study of perfused rat lungs, 10 M ryanodine had no effect on HPV, 100 M tended to reduce the response, and 300 M caused significant blunting. Interpreting this finding to mean that CICR contributes to the mechanism of HPV assumes that the relatively high concentration of ryanodine was required to inhibit Ca 2ϩ release and was not having a nonspecific effect. The lack of effect of ryanodine on baseline perfusion pressure in the isolated rat lungs suggests that ryanodine-sensitive, Ca 2ϩ sparkinduced stimulation of Ca 2ϩ -activated K ϩ channels (14, 30, 35, 48) plays no role in regulating the low resting vascular tone of this preparation.
Our finding of blunting instead of blockade of HPV by a high concentration of ryanodine differs somewhat from the recent observation that HPV in rat lungs is both completely prevented and reversed by the cADPribose antagonist 8-bromo-cADP-ribose (8) . Because hypoxia increases cADP-ribose in pulmonary artery smooth muscle (54) , cADP-ribose induces Ca 2ϩ release from ryanodine-sensitive stores (54) , and 8-bromocADP-ribose blocks sustained hypoxic contraction of isolated pulmonary arteries and hypoxic vasoconstriction of perfused lungs (8, 54) , Dipp and Evans (8) 10 M RD had no effect on the HPR to 3% O2, 100 M RD tended to reduce the response, and 300 M RD caused significant blunting. Distilled H2O (30, 150 , and 225 l) was added to perfusate of vehicle control lungs. Time after treatment is minutes after addition of either vehicle or ryanodine to perfusate. Values are means Ϯ SE; nos. in parentheses, no. of lungs. *P Ͻ 0.05 for RD 300 group vs. respective vehicle control group by ANOVA. Fig. 6 . Nifedipine (0.1 M) caused rapid and marked reversal of ongoing HPR to 3% inspired O2 in lungs pretreated with 200 M L-NNA and either Veh (150 l distilled H2O) or 100 M RD. Nifedipine was added to perfusate at peak of 3rd hypoxic response after addition of either vehicle or RD. Numbers in parentheses are means Ϯ SE of percent spontaneous reversal of 2nd hypoxic response within 2 min of peak and of percent reversal of 3rd hypoxic response within 2 min after adding nifedipine (n ϭ 3 for each group). *P Ͻ 0.05 for nifedipine reversal vs. respective spontaneous reversal.
influx. Although these investigators present a strong case that 8-bromo-cADP-ribose-induced inhibition of HPV is due to inhibition of release of SR Ca 2ϩ , our findings that high concentrations of ryanodine failed to abolish the hypoxic response and that the residual hypoxic vasoconstriction was immediately and markedly reversed by the voltage-gated Ca 2ϩ channel blocker nifedipine raise a note of caution. It would seem either that ryanodine failed to completely block CICR in our study or that 8-bromo-cADP-ribose had effects other than or in addition to inhibition of Ca 2ϩ release in the study of Dipp and Evans. With respect to the latter, one possibility that could be considered is that 8-bromo-cADP-ribose reversed a cADP-ribosemediated inhibition of a hyperpolarizing K ϩ current. For example, cADP-ribose has been reported to inhibit Ca 2ϩ -activated K ϩ channels in coronary arterial smooth muscle (17) and the activation of a voltagesensitive K ϩ current in neuroblastoma/glioma hybrid cells (3). Thus we suggest that further work is necessary to test whether 8-bromo-cADP-ribose-induced blockade of HPV in perfused rat lungs is due partly to activation of a hyperpolarizing K ϩ current and inhibition of Ca 2ϩ influx rather than solely to inhibition of release of SR Ca 2ϩ . Such a mechanism would be similar to the inhibition of HPV by blockade of the endothelin-1 ET A receptor that appears to be mediated through derepression of the ATP-sensitive K ϩ channel (36) . If, as our results suggest, both CICR and voltagegated Ca 2ϩ influx contribute to the intracellular Ca 2ϩ signal mediating HPV in PSS-perfused rat lungs, then the question arises as to which comes first. Some studies of PASMC indicate that hypoxia-induced release of intracellular Ca 2ϩ is the initiating event (10, 29, 34, 45) . However, voltage-gated Ca 2ϩ influx is a physiological trigger for ryanodine receptor-mediated CICR in vascular smooth muscle (7), and Cornfield et al. (6) have proposed that hypoxia-induced membrane depolarization and Ca 2ϩ influx trigger CICR in fetal PASMC.
In summary, our results in PSS-perfused rat lungs do not support evidence from studies of effects of thapsigargin and cyclopiazonic acid in PASMC and isolated pulmonary arteries (8, 10, 33, 34) that Ca 2ϩ release from an IP 3 -sensitive SR Ca 2ϩ store is an important component of the mechanism of HPV. However, our finding that relatively high concentrations of ryanodine blunt HPV agrees in principle with some studies of PASMC and isolated arteries (6, 8-10, 13, 18, 29, 45) and is consistent with the idea that Ca 2ϩ release from a ryanodine-sensitive SR Ca 2ϩ store contributes to the hypoxia-induced Ca 2ϩ signaling and vasoconstriction. What remains unclear are the relative roles and temporal relationships of voltage-gated Ca 2ϩ influx, CICR, voltage-independent Ca 2ϩ entry (33, 50) , and increased Ca 2ϩ sensitivity of contractile myofilaments (20, 32) in the overall mechanism of HPV, and to what extent the contribution of these various components is species and/or experimental preparation dependent. As emphasized in recent editorials by Sylvester (42) and Weissmann et al. (52) , many questions concerning the exact sequence of inter-and intracellular events underlying the mechanism of HPV remain to be definitively answered.
